An intrathecally-injected antisense oligonucleotide proposed to increase expression of the silenced ubiquitin protein ligase E3A gene for treatment of Angelman syndrome.
An intrathecally-injected antisense oligonucleotide proposed to increase expression of the silenced ubiquitin protein ligase E3A gene for treatment of Angelman syndrome.